Literature DB >> 10651168

Effects of N-acetylcysteine on nitroglycerin-induced relaxation and protein phosphorylation of porcine coronary arteries.

Y Tate1, K Kawasaki, S Ishibashi, U Ikeda, K Shimada.   

Abstract

We investigated the effects of the sulfhydryl-donor, N-acetylcysteine (NAC), on nitroglycerin (NTG)-induced relaxation of the vascular smooth muscle. Addition of histamine to isolated porcine coronary arteries induced an initial rapid contraction followed by a gradual decrease in tonic contraction. NTG applied to the coronary artery strips before histamine caused relaxation of the histamine-induced rapid (3 min) and tonic (48 min) contraction. The inhibition of the tonic contraction by NTG was less at 48 min than at 3 min. Application of NAC (NTG-NAC) enhanced the relaxing effects of NTG on the histamine-induced tonic contraction rather than the acute contraction. In phosphorylation studies, changes in the phosphorylation of an intermediate filament, desmin, were parallel with changes in contraction in NTG-treated and NTG-NAC samples at 48 min. These phosphorylation changes of desmin at 48 min, which might be responsible for tonic phase contraction, were more extensive than those of myosin light chain (MLC) phosphorylation at 3 min, which might be responsible for acute contraction. These results suggest that treatment with the sulfhydryl donor, NAC, inhibited the phosphorylation of desmin associated with the enhancement of NTG-induced relaxation, which might be related to the mechanisms of recovery from NTG tolerance by sulfhydryl groups.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10651168     DOI: 10.1007/bf03257230

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  32 in total

1.  Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine.

Authors:  J Dupuis; G Lalonde; R Lemieux; J L Rouleau
Journal:  J Am Coll Cardiol       Date:  1990-10       Impact factor: 24.094

2.  Tolerance to the vascular effects of glyceryl trinitrate.

Authors:  P Needleman
Journal:  J Pharmacol Exp Ther       Date:  1970-01       Impact factor: 4.030

3.  Effects of sulfhydryl reagents on nitroglycerin-induced relaxation of bovine coronary artery.

Authors:  C A Gruetter; S M Lemke
Journal:  Can J Physiol Pharmacol       Date:  1986-11       Impact factor: 2.273

4.  Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.

Authors:  K D Meisheri; L A Cipkus-Dubray; J M Hosner; S A Khan
Journal:  J Cardiovasc Pharmacol       Date:  1991-06       Impact factor: 3.105

5.  Tranilast inhibits contraction and Ca2+ movement of porcine coronary arteries.

Authors:  S Ishibashi; U Ikeda; T Ihara; K Shimada
Journal:  Atherosclerosis       Date:  1997-04       Impact factor: 5.162

6.  Nitroglycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concentrations measured with fura-2.

Authors:  T Yanagisawa; M Kawada; N Taira
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

Review 7.  Interactions between organic nitrates and thiol groups.

Authors:  J Abrams
Journal:  Am J Med       Date:  1991-09-30       Impact factor: 4.965

8.  Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine.

Authors:  J Torresi; J D Horowitz; G J Dusting
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.105

9.  Vascular smooth muscle relaxation by nitro compounds: reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol.

Authors:  K L Axelsson; R G Andersson; J E Wikberg
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-05

10.  Dissociation of cysteine and glutathione levels from nitroglycerin-induced relaxation.

Authors:  C A Gruetter; S M Lemke
Journal:  Eur J Pharmacol       Date:  1985-04-23       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.